TAKANASHI KEN 4
4 · Wave Life Sciences Ltd. · Filed Aug 7, 2025
Insider Transaction Report
Form 4
TAKANASHI KEN
Director
Transactions
- Sale
Ordinary Shares
2025-08-05$8.75/sh−4,872$42,630→ 5,716,303 total
Footnotes (1)
- [F1]On August 5, 2025, the reporting person sold 4,872 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025. These sales were made pursuant to a 10b5-1 Trading Plan.